drugset / Trial / NCT03441516
Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate the performance of Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) in patients with Alzheimer's disease (AD).
Timeline
- Start
- 2018-04-19
- Primary completion
- 2019-07-04
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Choline Alfoscerate | Unknown | 400 mg | Oral |
| Comparator | Donepezil | Small molecule | 10 mg | Oral |